Cargando…
Bisphosphonates and bone metastases.
Autores principales: | Morton, A. R., Howell, A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246834/ https://www.ncbi.nlm.nih.gov/pubmed/3064797 |
Ejemplares similares
-
Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate.
por: Dodwell, D. J., et al.
Publicado: (1990) -
Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein.
por: Walls, J., et al.
Publicado: (1994) -
Analysis of the Mechanism and Safety of Bisphosphonates in Patients with Lung Cancer and Bone Metastases
por: Zhang, Gao, et al.
Publicado: (2021) -
Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases
por: Aapro, Matti, et al.
Publicado: (2010) -
Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone Metastases
por: Pfannkuchen, Nina, et al.
Publicado: (2017)